Panzer Pharmaceutical Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 14-12-2024
- Paid Up Capital ₹ 0.10 M
as on 14-12-2024
- Company Age 27 Year, 6 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 0.10 M
as on 14-12-2024
- Revenue -26.72%
(FY 2021)
- Profit -24.84%
(FY 2021)
- Ebitda -20.50%
(FY 2021)
- Net Worth 10.64%
(FY 2021)
- Total Assets 3.41%
(FY 2021)
About Panzer Pharmaceutical
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹0.10 M.
Jayantilal Vekaria and Nayanaben Ramotia serve as directors at the Company.
- CIN/LLPIN
U24230GJ1997PTC032572
- Company No.
032572
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
24 Jun 1997
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Rajkot, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Panzer Pharmaceutical Private Limited offer?
Panzer Pharmaceutical Private Limited offers a wide range of products and services, including Common Disease Medicines, Pharmaceutical Tablets, Cosmetics, Hair & Beauty Products, Eye Cosmetic, Anti Infective Drugs & Medicines, Antifungal Injection, Tablet & Syrup, Anti Acne Drug, Skin Care Cosmetics, Hair Growth Medicine, Antifungal Cream, Ointment & Powder.
Who are the key members and board of directors at Panzer Pharmaceutical?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Jayantilal Vekaria  | Director | 25-Jun-2001 | Current |
| Nayanaben Ramotia | Director | 13-Jul-2010 | Current |
Financial Performance of Panzer Pharmaceutical.
Panzer Pharmaceutical Private Limited, for the financial year ended 2021, experienced significant reduction in revenue, with a 26.72% decrease. The company also saw a substantial fall in profitability, with a 24.84% decrease in profit. The company's net worth Soared by an impressive increase of 10.64%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Panzer Pharmaceutical?
In 2021, Panzer Pharmaceutical had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Yew Pharma Private LimitedActive 25 years 7 monthsJayantilal Vekaria and Nayanaben Ramotia are mutual person
- Onus Pharmaceutical Private LimitedActive 17 years 7 months
Jayantilal Vekaria and Nayanaben Ramotia are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
The Co-Op. Bank Of Rajkot Limited Creation Date: 01 Sep 1998 | ₹0.10 M | Open |
How Many Employees Work at Panzer Pharmaceutical?
Unlock and access historical data on people associated with Panzer Pharmaceutical, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Panzer Pharmaceutical, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Panzer Pharmaceutical's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
